Home › Trial NCT06724835
Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T)
- Trial IDNCT06724835
- StatusUnknown
- PhasePhase 1
- Study typeInterventional
- SponsorShenzhen Celconta Life Science Co., Ltd.
- Enrollment18
- Start date2024-03-11
- ConditionsAdvanced Breast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.